News | Artificial Intelligence | June 08, 2018

Zebra Medical Vision Unveils AI-Based Chest X-ray Research

Company also announces completion of $30M C round of financing

Zebra Medical Vision Unveils AI-Based Chest X-ray Research

June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future artificial intelligence (AI)-based automated chest X-ray analysis product the company is developing. Simultaneously, the company announced it has raised $30M in C round funding, bringing the total investment in the company to $50M.

This round of investment is led by aMoon Ventures, with the participation of strategic healthcare investors Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare, and leading global AI scientists Prof. Fei Fei Lee and Richard Socher. These new investors are joining a list of existing investors that includes Khosla Ventures, NVIDIA, Marc Benioff, OurCrowd and Dolby Ventures, who also participated in this C round.

The chest X-ray AI analytics product was trained using nearly 2 million images to identify 40 different common clinical findings. The results of the study demonstrate high rates of agreement between the algorithm and human radiologist experts.

Zebra Medical Vision has received the CE regulatory mark for seven of its products, as well as approvals in numerous countries across Latin America and Asia. Its most recent announcements were the CE approval of computed tomography (CT) brain bleed and mammography lesion detection algorithms. The company’s current and future arsenal of AI algorithms is bundled into a unique $1 per scan offering to hospitals, in order to provide scalable, transparent and affordable care solutions.

“Medical experts worldwide are facing a critical challenge in handling overwhelming demand. We are excited to partner with the Zebra-Med team, which is harnessing the power of data and machine learning to provide physicians and healthcare systems with tools to dramatically increase capacity, while improving patient care," said Yair Schindel, M.D., managing partner at aMoon VC. “This investment aligns with our vision of backing scalable and sustainable innovations that will have a valuable impact on fundamental facets of global healthcare.”

For more information: www.zebra-med.com

Reference

Laserson J., Lantsman C.D., Cohen-Sfady M., et al. "TextRay: Mining Clinical Reports to Gain a Broad Understanding of Chest X-rays," arxiv.org, June 6, 2018. arXiv:1806.02121

Related Content

Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
RaySearch Laboratories AB will demo its latest advances in oncology software at the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting
News | Radiation Oncology | October 23, 2020
October 23, 2020 — RaySearch will present recent and upcoming enhancements, as well as new functionality, in...
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...